DORM vs NVST
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
DORM · Dorman Products$136.70 ▼ 1.99%
NVST · Envista Holdings$25.17 ▲ 0.84%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- DORM +2.0%
- NVST +25.5%
Head to head
| Metric | DORM | NVST |
|---|---|---|
| Price | $136.70 | $25.17 |
| Change today | ▼ 1.99% | ▲ 0.84% |
| Market cap | $4.03B | $4.04B |
| Return, 3 months | +2.6% | -10.7% |
| Return, year to date | +11.0% | +15.9% |
| Return, 1 year | +1.8% | +29.4% |
| P/E (TTM) | 20.4 | 6.5 |
| P/B | 2.6 | 1.3 |
| P/E percentile vs own 5y | 39th | 76th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +3.3% | +7.1% |
| Net profit growth (YoY) | -22.6% | +103.4% |
| Gross margin | 41.1% | 55.2% |
| Operating margin | 15.9% | 10.3% |
| Net margin | 9.3% | 3.3% |
| Return on equity | 13.3% | 3.1% |
| Analyst target vs. price | +14.9% | +18.9% |
| Analyst buy share | 100% | 50% |
| RSI (14) | 60 | 55 |
| 30-day volatility | 31.9% | 47.9% |
| Max drawdown, 1 year | -34.6% | -26.0% |
| Trend read | Strong uptrend | Leaning bullish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- NVST is the largest of the group by market value.
- NVST has returned the most over the past year.
- NVST carries the lowest trailing P/E.
- NVST is growing revenue fastest.
- DORM keeps the most profit per dollar of sales.
- DORM has been the calmest stock over the last 30 days.